The outcome of Proposal 4 is uncertain and will be determined at the reconvened meeting on October 30. If approved, the warrant exercise could lead to dilution. Monitor stockholder voting patterns and any subsequent 8-K filing announcing the result.
Price Chart
Executive Summary
BIO-key International filed additional definitive proxy soliciting materials (DEFA14A) to urge stockholders to vote in favor of Proposal 4 at the reconvened 2026 Annual Meeting on October 30, 2026. Proposal 4 seeks approval to issue up to 1,236,668 shares of common stock upon exercise of warrants issued in the August 10, 2026 warrant inducement transaction, as required by NASDAQ Listing Rule 5635(d). The meeting was adjourned from October 2 to allow more time for voting on this proposal, while Proposals 1, 2, and 3 were already approved.
Key Financial Metrics
Key Facts
- Annual Meeting reconvened on October 2, 2026; Proposals 1, 2, and 3 approved.
- Proposal 4 seeks approval to issue up to 1,236,668 shares upon exercise of warrants from the August 10, 2026 warrant inducement transaction.
- Meeting adjourned to October 30, 2026 at 10:00 a.m. local time in Holmdel, NJ to allow more time for voting on Proposal 4.
- Record date remains July 15, 2026.
- Company is actively soliciting votes in favor of Proposal 4 via this DEFA14A filing.
Financial Impact
Up to 1,236,668 shares of common stock issuable upon warrant exercise; potential dilution depends on exercise price and stock price at time of exercise.
Risk Factors
- Failure to pass Proposal 4 could limit the company's ability to issue shares upon warrant exercise, potentially affecting capital structure or NASDAQ compliance.
- Approval of Proposal 4 could result in dilution for existing stockholders if warrants are exercised.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001437749-26-032238 |
| Document: 0001437749-26-032238-index-headers.html | 0001437749-26-032238 |
| Document: 0001437749-26-032238-index.html | 0001437749-26-032238 |
| Document: 0001437749-26-032238.txt | 0001437749-26-032238 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | S-1 | $1.65 | awaiting T+60 | — | $2.85 (−72.73%) |
Oct 6, 2026 20d ago | DEFA14A | $1.76 | awaiting T+60 | — | $2.85 (+61.93%) |
Oct 6, 2026 20d ago | 8-K | $1.76 | awaiting T+60 | — | $2.85 (+61.93%) |
Oct 2, 2026 24d ago | 8-K | $1.93 | awaiting T+60 | — | $2.85 (−47.67%) |
Sep 29, 2026 28d ago | Press Release | $3.12 | awaiting T+60 | — | $2.85 (−8.65%) |
Aug 24, 2026 9w ago | DEFA14A | $2.97 | awaiting T+60 | — | $2.85 (+4.04%) |
Aug 14, 2026 10w ago | 8-K | $3.18 | awaiting T+60 | — | $2.85 (+10.38%) |
Aug 13, 2026 10w ago | Press Release | $3.18 | awaiting T+60 | — | $2.85 (−10.38%) |
Aug 10, 2026 11w ago | Press Release | $4.17 | awaiting T+60 | — | $2.85 (−31.65%) |
Jul 28, 2026 13w ago | Press Release | $4.25 $2.10 | ▼ −50.59% | ▼ −54.94% | $2.85 (−32.94%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers